101 related articles for article (PubMed ID: 1311787)
21. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
Karasawa H; Miwa T
Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
[TBL] [Abstract][Full Text] [Related]
22. Irreversible inactivation of rat gastric (H+-K+)-ATPase in vivo by omeprazole.
Im WB; Blakeman DP; Davis JP
Biochem Biophys Res Commun; 1985 Jan; 126(1):78-82. PubMed ID: 2982382
[TBL] [Abstract][Full Text] [Related]
23. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
[TBL] [Abstract][Full Text] [Related]
24. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
Shamburek RD; Schubert ML
Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
[TBL] [Abstract][Full Text] [Related]
25. Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis.
Kamath BS; Srikanta BM; Dharmesh SM; Sarada R; Ravishankar GA
Eur J Pharmacol; 2008 Aug; 590(1-3):387-95. PubMed ID: 18602387
[TBL] [Abstract][Full Text] [Related]
26. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
[TBL] [Abstract][Full Text] [Related]
27. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
[TBL] [Abstract][Full Text] [Related]
28. Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection.
Wada I; Otaka M; Jin M; Odashima M; Komatsu K; Konishi N; Matsuhashi T; Horikawa Y; Ohba R; Itoh H; Watanabe S
Biochem Biophys Res Commun; 2006 Oct; 349(2):611-8. PubMed ID: 16945336
[TBL] [Abstract][Full Text] [Related]
29. Specific labelling of gastric H+,K+-ATPase by omeprazole.
Fryklund J; Gedda K; Wallmark B
Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
[TBL] [Abstract][Full Text] [Related]
30. Interaction of anti-ulcer drugs with the gastric proton pump.
Saccomani G; Hersey SJ
Drug Metabol Drug Interact; 1989; 7(2-3):161-89. PubMed ID: 2560952
[TBL] [Abstract][Full Text] [Related]
31. The effect of DQ-2511, a newly synthesized anti-ulcer drug, on the gastric mucosal hemodynamics and ulceration in rats.
Tanimura H; Sato N; Kawano S; Tsujii M; Hayashi N; Sakura H; Tsujii S; Ogihara T; Kamada T
Scand J Gastroenterol Suppl; 1989; 162():190-3. PubMed ID: 2595295
[TBL] [Abstract][Full Text] [Related]
32. Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors.
Sih JC; Im WB; Robert A; Graber DR; Blakeman DP
J Med Chem; 1991 Mar; 34(3):1049-62. PubMed ID: 1848293
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of gastric ulcers with proton pump inhibitors--long-term treatment].
Aoki T; Akimoto H; Takayama S
Nihon Rinsho; 1992 Jan; 50(1):181-7. PubMed ID: 1311784
[TBL] [Abstract][Full Text] [Related]
34. [Effects of 3,4,5-trimethoxy-N-(3-piperidyl) benzamide (KU-54) on respiration of the gastric mucosa and liver in rats].
Abe Y; Sekiguchi H; Tsuru K; Irikura T
Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):317-24. PubMed ID: 6745811
[TBL] [Abstract][Full Text] [Related]
35. [Characteristic features of proton pump inhibitors in the inhibition of gastric acid secretion: long-acting and complete inhibition].
Ohe K
Nihon Rinsho; 1992 Jan; 50(1):45-52. PubMed ID: 1311789
[TBL] [Abstract][Full Text] [Related]
36. Gastric H,K-ATPase as therapeutic target.
Sachs G; Carlsson E; Lindberg P; Wallmark B
Annu Rev Pharmacol Toxicol; 1988; 28():269-84. PubMed ID: 2898235
[No Abstract] [Full Text] [Related]
37. The effect of a new gastric proton pump inhibitor on serotonin-induced gastric mucosal lesions in rats.
Tsukamoto Y; Nakazawa S; Segawa K; Goto H; Fukui A; Takano K; Hase S; Arisawa T; Osada T; Kawabe Y
Gastroenterol Jpn; 1988 Oct; 23(5):501-5. PubMed ID: 3215434
[TBL] [Abstract][Full Text] [Related]
38. Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification.
Howden CW; Reid JL
Eur J Clin Pharmacol; 1984; 26(5):639-40. PubMed ID: 6088253
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of the gastric mucosal defense mechanism induced by KW-5805, a novel antiulcer agent.
Tanaka H; Kosaka N; Tomaru A; Shuto K; Ogihara T; Sato N
Scand J Gastroenterol Suppl; 1989; 162():170-3. PubMed ID: 2595291
[TBL] [Abstract][Full Text] [Related]
40. Effects of verapamil on gastric acid secretion in vitro and in vivo.
Herling AW; Ljungström M
Eur J Pharmacol; 1988 Nov; 156(3):341-50. PubMed ID: 2850932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
